Publications by authors named "Mohammed Arish"

Article Synopsis
  • The study focuses on optic neuritis (ON) as a potential early sign of multiple sclerosis (MS) and develops a predictive model to identify patients at risk of developing MS.
  • Data from the Optic Neuritis Treatment Trial included 457 patients, with a final analysis of 388 patients revealing that specific factors like MRI lesions and ON type significantly influence the risk of developing clinically definite MS.
  • The decision tree model demonstrated a decent accuracy of around 70%, helping physicians make informed decisions about patient care based on individual risk factors.
View Article and Find Full Text PDF
Article Synopsis
  • This study evaluates the effects of brimonidine on visual functions, specifically contrast sensitivity in patients with acute optic neuritis.
  • Conducted as a randomized clinical trial with 60 participants, it compared the outcomes of those treated with brimonidine to a control group receiving synthetic tears over three months.
  • Results showed significant improvements in contrast sensitivity and visual acuity for the brimonidine group, indicating its potential neuroprotective benefits for retinal ganglion cell function.
View Article and Find Full Text PDF

The long-term physiological consequences of respiratory viral infections, particularly in the aftermath of the COVID-19 pandemic-termed post-acute sequelae of SARS-CoV-2 (PASC)-are rapidly evolving into a major public health concern. While the cellular and molecular aetiologies of these sequelae are poorly defined, increasing evidence implicates abnormal immune responses and/or impaired organ recovery after infection. However, the precise mechanisms that link these processes in the context of PASC remain unclear.

View Article and Find Full Text PDF

Introduction: Predicting the conversion of clinically isolated syndrome (CIS) to clinically definite multiple sclerosis (CDMS) is critical to personalizing treatment planning and benefits for patients. The aim of this study is to develop an explainable machine learning (ML) model for predicting this conversion based on demographic, clinical, and imaging data.

Method: The ML model, Extreme Gradient Boosting (XGBoost), was employed on the public dataset of 273 Mexican mestizo CIS patients with 10-year follow-up.

View Article and Find Full Text PDF
Article Synopsis
  • The long-term effects of COVID-19, known as Post-Acute Sequelae of COVID-19 (PASC), are becoming a major public health issue linked to poor recovery of organs and abnormal immune responses post-infection.
  • A mouse model was developed to study patients with respiratory PASC, revealing unique immune cell interactions that disrupt lung cell regeneration and contribute to lung fibrosis after initial infection.
  • Interventions targeting certain inflammatory signals were found to improve lung recovery, suggesting potential therapeutic strategies to address fibrosis that develops from respiratory viral infections.
View Article and Find Full Text PDF

Background: The recurrence rate plays a key role in using various treatments of pterygium. This study assessed the effectiveness of argon laser therapy before the excision of pterygium on the recurrence rate.

Materials And Methods: The eyes ( = 60) of patients ( = 30) were divided into two groups based on the treatment.

View Article and Find Full Text PDF

The long-term physiological consequences of SARS-CoV-2, termed Post-Acute Sequelae of COVID-19 (PASC), are rapidly evolving into a major public health concern. The underlying cellular and molecular etiology remain poorly defined but growing evidence links PASC to abnormal immune responses and/or poor organ recovery post-infection. Yet, the precise mechanisms driving non-resolving inflammation and impaired tissue repair in the context of PASC remain unclear.

View Article and Find Full Text PDF

Purpose: Vernal keratoconjunctivitis (VKC) is a bilateral, chronic, external ocular inflammatory disorder that mainly affects patients in their first or second decade. This study was designed to compare tacrolimus and interferon alpha-2b (IFN alpha-2b) eye drops in the treatment of VKC.

Methods: In this randomized, double-masked clinical trial, 40 consecutive patients with VKC were sent to a referral eye hospital in a tropical region southeast of Iran.

View Article and Find Full Text PDF

Background: Pterygium is the human eye lesion whose prevalence in the general population is estimated about 2%. The disease, in extreme phase, can lead to visual disturbance and eventually causes complete loss of vision due to the lesion growth over the papillary axis. Pterygium invasive tissue is a tumor-like tissue that is initially identified and then is attacked by cytotoxic T cells.

View Article and Find Full Text PDF